Mallinckrodt closes acquisition of Endo; Endo shares converted to 0.2575 MNK shares + $1.31 cash

Endo LP

Endo shareholders received 0.2575 Mallinckrodt ordinary shares and about $1.31 cash per share, with cash for fractional shares.
Endo common stock delisted from OTCQX; Form 15 to be filed to suspend SEC reporting obligations.
All prior directors (Herendeen, Efron, Hirsch, Langlois, Pasternak, Yoskowitz) removed; Matthew Peters and Mark Tyndall appointed sole directors.
Ex-CEO Scott Hirsch to serve as senior advisor for 60 days, then consultant for 6 months, receiving $750,000/month for 12 months ($9M total).
Endo converted into Endo LP on August 1, 2025; board approved $645,000 incremental payment to directors for equity awards.

item 2.01item 3.01item 3.03item 5.01item 5.02item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.